Trending news

Konstantin Linnik Quoted on ‘Cabilly Patents’ in Reuters

Print PDF

Konstantin Linnik, Ph.D., a partner in Nutter's Intellectual Property Department, was quoted in a Reuters article that analyzed the effect that the expiring 'Cabilly patents' will have on Landmark Roche and the biotechnology market as a whole. In the article, "'Double whammy' for Roche as manufacturing patent losses loom," Konstantin commented, "Drug companies that fought unsuccessfully multiple legal battles against the longest-lived biotech patents – effectively 29 years — will no longer face the Cabilly bottleneck."

More News >
Back to Page